Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 29;74(2):171-179.
doi: 10.1093/cid/ciab428.

Tracing People Living With Human Immunodeficiency Virus Who Are Lost to Follow-up at Antiretroviral Therapy Programs in Southern Africa: A Sampling-Based Cohort Study in 6 Countries

Affiliations

Tracing People Living With Human Immunodeficiency Virus Who Are Lost to Follow-up at Antiretroviral Therapy Programs in Southern Africa: A Sampling-Based Cohort Study in 6 Countries

Marie Ballif et al. Clin Infect Dis. .

Abstract

Background: Attrition threatens the success of antiretroviral therapy (ART). In this cohort study, we examined outcomes of people living with human immunodeficiency virus (PLHIV) who were lost to follow-up (LTFU) during 2014-2017 at ART programs in Southern Africa.

Methods: We confirmed LTFU (missed appointment for ≥60 or ≥90 days, according to local guidelines) by checking medical records and used a standardized protocol to trace a weighted random sample of PLHIV who were LTFU in 8 ART programs in Lesotho, Malawi, Mozambique, South Africa, Zambia, and Zimbabwe, 2017-2019. We ascertained vital status and identified predictors of mortality using logistic regression, adjusted for sex, age, time on ART, time since LTFU, travel time, and urban or rural setting.

Results: Among 3256 PLHIV, 385 (12%) were wrongly categorized as LTFU and 577 (17%) had missing contact details. We traced 2294 PLHIV (71%) by phone calls, home visits, or both: 768 (34% of 2294) were alive and in care, including 385 (17%) silent transfers to another clinic; 528 (23%) were alive without care or unknown care; 252 (11%) had died. Overall, the status of 1323 (41% of 3256) PLHIV remained unknown. Mortality was higher in men than women, higher in children than in young people or adults, and higher in PLHIV who had been on ART <1 year or LTFU ≥1 year and those living farther from the clinic or in rural areas. Results were heterogeneous across sites.

Conclusions: Our study highlights the urgent need for better medical record systems at HIV clinics and rapid tracing of PLHIV who are LTFU.

Keywords: HIV; Southern Africa; lost to follow-up; tracing; vital status.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Study flowchart. Abbreviations: ART, antiretroviral therapy; LTFU, lost to follow-up; PLHIV, people living with HIV.
Figure 2.
Figure 2.
Vital status and care outcomes among participants who were traced, by antiretroviral therapy program and overall. Abbreviations: LTFU, lost to follow-up; MoH-CIDRZ, Ministry of Health–Centre for Infectious Disease Research in Zambia; SMART, SolidarMed-supported antiretroviral therapy program.
Figure 3.
Figure 3.
Differences across antiretroviral therapy programs in the proportions of participants confirmed lost to follow-up, medical records not found, alive or who have died, among those sampled (first bar), the subgroup of those traced (second bar), and the combined outcomes (third bar). Abbreviations: LTFU, lost to follow-up; MoH-CIDRZ, Ministry of Health–Centre for Infectious Disease Research in Zambia; SMART, SolidarMed-supported antiretroviral therapy program.
Figure 4.
Figure 4.
Univariable and multivariable logistic regressions of mortality, among 1548 participants who were traced with determined vital status. Abbreviations: ART, antiretroviral therapy; CI, confidence interval; OR, odds ratio.
Figure 5.
Figure 5.
Univariable and multivariable logistic regressions of being in care, among 1193 participants who were traced and found alive. Abbreviations: ART, antiretroviral therapy; CI, confidence interval; OR, odds ratio.

Similar articles

Cited by

References

    1. Geng EH, Odeny TA, Lyamuya R, et al. . Retention in care and patient-reported reasons for undocumented transfer or stopping care among HIV-infected patients on antiretroviral therapy in Eastern Africa: application of a sampling-based approach. Clin Infect Dis 2016; 62:935–44. - PMC - PubMed
    1. Zürcher K, Mooser A, Anderegg N, et al. ; IeDEA and MESH Consortia . Outcomes of HIV-positive patients lost to follow-up in African treatment programmes. Trop Med Int Health 2017; 22:375–87. - PMC - PubMed
    1. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health 2010; 15:1–15. - PMC - PubMed
    1. Geng EH, Nash D, Kambugu A, et al. . Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep 2010; 7:234–44. - PMC - PubMed
    1. Fox MP, Rosen S. Systematic review of retention of pediatric patients on HIV treatment in low and middle-income countries 2008–2013. AIDS (London, England) 2015; 29:493–502. - PubMed

Publication types

Substances